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In this study, we propose a new solution for the nanoencapsulation of hydrophilic
anticancer drug, doxorubicin hydrochloride (DOX). The drug molecules are solubilized
in the core of aqueous nanoreservoirs, so-called aqueous core nanocapsules (ACN)
recently developed by our team, and dispersed in aqueous bulk media. Since it is well
acknowledged that the nanoencapsulation of DOX has many advantages, like reducing
the sides effects (e.g. cardiac toxicity), we propose through the present study a novel
formulation solution for this purpose. After focusing on the formulation process for
optimizing the drug encapsulation yield, the DOX-release profiles were followed up
and analyzed. Different physicochemical and in vitro characterization were performed,
and complement activation experiments. ACN were shown efficient to encapsulate
DOX reaching yields as high as 80%, followed by a sustained release governed by a
diffusion-controlled mechanism. The loaded nanocarriers showed low levels of
complement activation, compatible with stealth properties. To summarize, this study
brings out a new tool for the nanoencapsulation of hydrophilic anticancers and could
open new doors for the administration of this particular class of drugs.
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